Top Markets
Coin of the day
NeoCore Technology Co., Ltd. NeoCore Technology Co., Ltd.

NeoCore Technology Co., Ltd.

4131
Pozycja w akcjach #26461
NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture,... NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture, and distribution of biochips and advanced rapid nucleic acid hybridization devices. Their extensive product range features systems designed for food safety screening, human diagnostic arrays, agricultural analysis, and specific food examination arrays, in addition to a variety of laboratory instruments and DNA kits. The company further provides a suite of services, encompassing laboratory planning, design, and additional specialized support. Beyond its core biotech operations, NeoCore also participates in the wholesale and retail market for contact lenses. The firm, which was established in 1987 and is based in Tainan, Taiwan, underwent a name change in July 2023, transitioning from its former identity as DR. Chip Biotechnology Incorporation to its current name.
Cena akcji
$1.02
Kapitalizacja rynkowa
$40.42M
Zmiana (1 dzień)
-1.08%
Zmiana (1 rok)
-10.53%
Kraj
TW
Handel NeoCore Technology Co., Ltd. (4131)

Kategoria

Historia stopy dywidendy dla NeoCore Technology Co., Ltd. (4131)
Stopa dywidendy (TTM) dla NeoCore Technology Co., Ltd. (symbol akcji: 4131) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla NeoCore Technology Co., Ltd. (4131) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji